Literature DB >> 1846596

Novel downstream elements upregulate transcription initiated from an Epstein-Barr virus latent promoter.

D Walls1, M Perricaudet.   

Abstract

The modulation of nuclear antigen expression from the Epstein-Barr virus (EBV) genome in virus-infected cells is crucial to the establishment and maintenance of the immortalized state. The EBV nuclear antigen (EBNA) genes are all transcribed from either of two promoters whose alternate usage is not understood. We have studied the EBNA transcriptional domain by using various promoter constructs to transfect a variety of EBV positive cell lines and then measured promoter activity by RNase protection analysis and nuclear run-on transcription assay. These experiments have shown that at least two distinct and novel DNA sequence elements are located in the intronic region situated between both promoters and that their presence results in a 100-fold stimulation of transcription initiated from the upstream promoter. One of these elements is shown to bind nuclear proteins from an EBV-positive cell line. In addition, an important sequence homology is noted between this element and the core sequences of a number of well known viral enhancers. Taken together, the results show that EBNA transcription is controlled by upstream and intronic elements in a regulatory domain that is at least 7 kb long.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1846596      PMCID: PMC452622          DOI: 10.1002/j.1460-2075.1991.tb07930.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  46 in total

1.  Identification of sequences in Epstein-Barr virus DNA required for the expression of the second Epstein-Barr virus-determined nuclear antigen in COS-1 cells.

Authors:  A Ricksten; C Svensson; C Welinder; L Rymo
Journal:  J Gen Virol       Date:  1987-09       Impact factor: 3.891

2.  Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cells.

Authors:  A Calender; M Billaud; J P Aubry; J Banchereau; M Vuillaume; G M Lenoir
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

3.  A promoter of Epstein-Barr virus that can function during latent infection can be transactivated by EBNA-1, a viral protein required for viral DNA replication during latent infection.

Authors:  B Sugden; N Warren
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

4.  Size and stability of the Epstein-Barr virus major internal repeat (IR-1) in Burkitt's lymphoma and lymphoblastoid cell lines.

Authors:  G J Allan; D T Rowe
Journal:  Virology       Date:  1989-12       Impact factor: 3.616

5.  Significant potential secondary structures in the Epstein-Barr virus genome.

Authors:  S Karlin
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

6.  Nucleotide sequences of mRNAs encoding Epstein-Barr virus nuclear proteins: a probable transcriptional initiation site.

Authors:  J Sample; M Hummel; D Braun; M Birkenbach; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

7.  Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.

Authors:  F Wang; C D Gregory; M Rowe; A B Rickinson; D Wang; M Birkenbach; H Kikutani; T Kishimoto; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

8.  The 5' flanking region of the gene for the Epstein-Barr virus-encoded nuclear antigen 2 contains a cell type specific cis-acting regulatory element that activates transcription in transfected B-cells.

Authors:  A Ricksten; A Olsson; T Andersson; L Rymo
Journal:  Nucleic Acids Res       Date:  1988-09-12       Impact factor: 16.971

9.  Mutually exclusive use of viral promoters in Epstein-Barr virus latently infected lymphocytes.

Authors:  M Woisetschlaeger; J L Strominger; S H Speck
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

10.  Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes.

Authors:  W Hammerschmidt; B Sugden
Journal:  Nature       Date:  1989-08-03       Impact factor: 49.962

View more
  11 in total

1.  Protein-DNA binding and CpG methylation at nucleotide resolution of latency-associated promoters Qp, Cp, and LMP1p of Epstein-Barr virus.

Authors:  D Salamon; M Takacs; D Ujvari; J Uhlig; H Wolf; J Minarovits; H H Niller
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

2.  Epstein-barr virus (EBV) nuclear protein 2-induced disruption of EBV latency in the Burkitt's lymphoma cell line Akata: analysis by tetracycline-regulated expression.

Authors:  S Fujiwara; Y Nitadori; H Nakamura; T Nagaishi; Y Ono
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

3.  The amino acid region 248-382 of the Epstein-Barr virus nuclear protein 2 (EBNA2) is responsible for the EBNA2-induced EBV reactivation.

Authors:  S Fujiwara; E Liu; K Shimizu
Journal:  Virus Genes       Date:  2001-12       Impact factor: 2.332

4.  Host-cell-phenotype-dependent control of the BCR2/BWR1 promoter complex regulates the expression of Epstein-Barr virus nuclear antigens 2-6.

Authors:  E Altiok; J Minarovits; L F Hu; B Contreras-Brodin; G Klein; I Ernberg
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-01       Impact factor: 11.205

5.  Methylation status of the Epstein-Barr virus (EBV) BamHI W latent cycle promoter and promoter activity: analysis with novel EBV-positive Burkitt and lymphoblastoid cell lines.

Authors:  Isabel A Hutchings; Rosemary J Tierney; Gemma L Kelly; Julianna Stylianou; Alan B Rickinson; Andrew I Bell
Journal:  J Virol       Date:  2006-08-18       Impact factor: 5.103

6.  Reciprocal antagonism of steroid hormones and BZLF1 in switch between Epstein-Barr virus latent and productive cycle gene expression.

Authors:  A J Sinclair; M Brimmell; P J Farrell
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

7.  Host cell and EBNA-2 regulation of Epstein-Barr virus latent-cycle promoter activity in B lymphocytes.

Authors:  C M Rooney; M Brimmell; M Buschle; G Allan; P J Farrell; J L Kolman
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

8.  B-cell lines immortalized with an Epstein-Barr virus mutant lacking the Cp EBNA2 enhancer are biased toward utilization of the oriP-proximal EBNA gene promoter Wp1.

Authors:  L I Yoo; M Mooney; M T Puglielli; S H Speck
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

9.  Regulation of EBNA gene transcription in lymphoblastoid cell lines: characterization of sequences downstream of BCR2 (Cp).

Authors:  M T Puglielli; N Desai; S H Speck
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

10.  Molecular genetic analysis of Epstein-Barr virus Cp promoter function.

Authors:  T J Evans; P J Farrell; S Swaminathan
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.